コンテンツへスキップ
Merck
すべての画像(3)

主要文書

安全性情報

SAB4504190

Sigma-Aldrich

Anti-phospho-HDAC6 (pSer22) antibody produced in rabbit

affinity isolated antibody

別名:

Anti-CPBHM, Anti-HD6, Anti-JM21, Anti-PPP1R90

ログイン組織・契約価格を表示する


About This Item

UNSPSCコード:
12352203
NACRES:
NA.41

由来生物

rabbit

品質水準

結合体

unconjugated

抗体製品の状態

affinity isolated antibody

抗体製品タイプ

primary antibodies

クローン

polyclonal

形状

buffered aqueous solution

分子量

antigen 131 kDa

化学種の反応性

human, rat, mouse

濃度

~1 mg/mL

テクニック

ELISA: 1:1000
immunofluorescence: 1:100-1:500
immunohistochemistry: 1:50-1:100
western blot: 1:500-1:1000

NCBIアクセッション番号

UniProtアクセッション番号

輸送温度

wet ice

保管温度

−20°C

ターゲットの翻訳後修飾

phosphorylation (pSer22)

遺伝子情報

human ... HDAC6(10013)

詳細

Histone deacetylases 6 (HDAC6) is encoded by the gene mapped to human chromosome Xp11.23. It belongs to the class IIb histone deacetylase family of enzymes, that remove acetyl groups from lysine residues. This protein is present mainly in cytosol.

免疫原

The antiserum was produced against synthesized peptide derived from human HDAC6 around the phosphorylation site of Ser22.

Immunogen Range: 7-56

生物化学的/生理学的作用

Histone deacetylases 6 (HDAC6) is associated with various cellular processes such as regulation of microtubules, growth factor-induced chemotaxis, misfolded protein stress response, and tumor invasion. Increased expression of HDAC6 might promote tumorigenesis by upregulating the expression of c-myc. Overexpression of HDAC6 is seen in acute myeloid leukemia and some breast cancer patients. Oncogenic K-ras imparts suberoylanilide hydroxamic acid (SAHA) resistance via increasing HDAC6 and c-myc expression. HDAC6 controls cellular protective response against cytotoxic accumulation of toxic bioproducts. HDAC6 Inhibition is considered to be a potential therapeutic strategy for treating inflammatory breast cancer (IBC) patients. HDAC6 and acetylated α-tubulin play a vital role in regulation of adipocyte differentiation.

特徴および利点

Evaluate our antibodies with complete peace of mind. If the antibody does not perform in your application, we will issue a full credit or replacement antibody. Learn more.

物理的形状

ウサギIgGのPBS溶液(Mg2+およびCa2+を含まず)、pH 7.4、150 mM NaCl、0.02% アジ化ナトリウム、50% グリセロール

免責事項

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

適切な製品が見つかりませんか。  

製品選択ツール.をお試しください

保管分類コード

10 - Combustible liquids

WGK

WGK 1

引火点(°F)

Not applicable

引火点(℃)

Not applicable


適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

Jan Code

SAB4504190-100UG:


試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Preeti Putcha et al.
Breast cancer research : BCR, 17(1), 149-149 (2015-12-09)
Inflammatory breast cancer (IBC) is the most lethal form of breast cancers with a 5-year survival rate of only 40 %. Despite its lethality, IBC remains poorly understood which has greatly limited its therapeutic management. We thus decided to utilize an
Nicolas Forcioli-Conti et al.
Biochimie, 124, 112-123 (2015-09-13)
The primary cilium is an organelle present in most of the cells of the organism. Ciliopathies, such as the Bardet Biedl and the Alstrom syndromes are associated with obesity. We, and others, have shown that the primary cilium undergoes size
Assignment of the human histone deacetylase 6 gene (HDAC6) to X chromosome p11.23 by in situ hybridization.
U Mahlknecht et al.
Cytogenetics and cell genetics, 93(1-2), 135-136 (2001-07-28)
Qun Wang et al.
Oncotarget, 7(9), 10064-10072 (2016-02-06)
Histone deacetylase inhibitors (HDIs) represent a new class of anticancer drugs. Suberoylanilide hydroxamic acid (SAHA), the first HDI approved for the treatment of cutaneous T cell lymphoma (CTCL), is currently being tested in clinical trials for other cancers. However, SAHA

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)